Pfizer Inc (NYSE:PFE) shares traded on -1.03% below secure line and closed at $42.44. The stock exchanged hands 18.43 Million shares versus average trading capacity of 26.5 Million shares. It has a market cap of $248.03 Billion.

Wall Street analysts are predicting that Pfizer Inc (NYSE:PFE) will report earnings per share of $0.63 in their quarterly report. For the current quarter Pfizer Inc (NYSE:PFE) has high EPS estimates of $0.64 in contradiction of low EPS estimates of $0.62. However a year ago for the same quarter the company has reported $0.62 EPS. Average estimation for the current quarter has been provided by 11 analysts.

Investors as well as the sell-side will be paying close attention to how the actual numbers compare with the estimates. Earnings surprises can have a huge impact on a company’s stock price. Several studies suggest that positive earnings surprises not only lead to an immediate hike in a stock’s price, but also to a gradual increase over time. Hence, it’s not surprising that some companies are known for routinely beating earning projections. A negative earnings surprise will usually result in a decline in share price.

A large surprise factor in either direction typically can lead to a significant swing in the stock price in the hours and days after the report. Previously Pfizer Inc (NYSE:PFE) reported $0.78 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.75 by $0.03 with surprise factor of 4%.

Pfizer Inc (NYSE:PFE) has average revenue estimates of $13.91 Billion, compared to low analyst estimates of $13.75 Billion and high estimates of $14.13 Billion for the current quarter. A total number of 9 analysts provided estimations over revenues. For the current year the company’s revenue estimates are $53.54 Billion compared to low analyst estimates of $53.18 Billion and high estimates of $53.8 Billion according to the prediction of 14 analysts.

Taking a broader look at the analyst consensus, according to 13 analysts Pfizer Inc (NYSE:PFE)’s price will reach at $44.77 during 52 weeks. Its minimum price target estimates has been figured out at $36 while the maximum price target forecast is established at $54.

On the other hand Pfizer Inc (NYSE:PFE) has Relative Strength Index (RSI 14) of 49.3 along with Average True Range (ATR 14) of 0.99. Where the relative strength index (RSI) is a technical momentum indicator that compares the magnitude of recent gains to recent losses in an attempt to determine excess buying & selling conditions of an asset, it is one of the most popular technical indicators, computed on the basis of the speed and direction of a stock’s price movement. The RSI value will always move between 0 and 100; the value will be 0 if the stock falls on all 14 days, and 100, if the price moves up on all the days) as suggested by J Welles Wilder. In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. The level of 50 represents neutral market momentum and corresponds with the center line in other oscillators such as MACD (Moving Average Convergence/Divergence). The average true range (ATR) is a measure of volatility introduced by Welles Wilder.

Consequently Pfizer Inc (NYSE:PFE)’s weekly and monthly volatility is 2.50%, 2.04% respectively.